Neurofilament light chain antibodies are correlated to disability in multiple sclerosis

被引：0
|
作者：
Burgal, M [1 ]
Garcia, S [1 ]
Hernández, A [1 ]
Lafuente, E [1 ]
Martinez, I [1 ]
Casanova, B [1 ]
Coret, F [1 ]
Bosco, I [1 ]
机构：
[1] Univ Valencia, Hosp La Fe, Hosp Clin, Inst Invest Citol, Valencia, Spain
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy
    Eikelenboom, MJ
    Petzold, A
    Lazeron, RHC
    Silber, E
    Sharief, M
    Thompson, EJ
    Barkhof, F
    Giovannoni, G
    Polman, CH
    Uitdehaag, BMJ
    NEUROLOGY, 2003, 60 (02) : 219 - 223
  • [2] Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
    Abdelhak, Ahmed
    Benkert, Pascal
    Schaedelin, Sabine
    Boscardin, W. John
    Cordano, Christian
    Oechtering, Johanna
    Ananth, Kirtana
    Granziera, Cristina
    Melie-Garcia, Lester
    Montes, Shivany Condor
    Beaudry-Richard, Alexandra
    Achtnichts, Lutz
    Oertel, Frederike C.
    Lalive, Patrice H.
    Leppert, David
    Mueller, Stefanie
    Henry, Roland G.
    Pot, Caroline
    Matthias, Amandine
    Salmen, Anke
    Oksenberg, Jorge R.
    Disanto, Giulio
    Zecca, Chiara
    D'Souza, Marcus
    Du Pasquier, Renaud
    Bridel, Claire
    Gobbi, Claudio
    Kappos, Ludwig
    Hauser, Stephen L.
    Cree, Bruce A. C.
    Kuhle, Jens
    Green, Ari J.
    JAMA NEUROLOGY, 2023, 80 (12) : 1317 - 1325
  • [3] The Evolution of Neurofilament Light Chain in Multiple Sclerosis
    Ferreira-Atuesta, Carolina
    Reyes, Saul
    Giovanonni, Gavin
    Gnanapavan, Sharmilee
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [4] Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
    Pukoli, Daniel
    Polyak, Helga
    Rajda, Cecilia
    Vecsei, Laszlo
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [5] Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
    Varhaug, Kristin N.
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    Vedeler, Christian A.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [6] Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
    Puentes, Fabiola
    Benkert, Pascal
    Amor, Sandra
    Kuhle, Jens
    Giovannoni, Gavin
    BMJ NEUROLOGY OPEN, 2021, 3 (02)
  • [7] Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis
    Husseini, Leila
    Jung, Jakob
    Boess, Natalie
    Kruse, Niels
    Nessler, Stefan
    Stadelmann, Christine
    Metz, Imke
    Haupts, Michael
    Weber, Martin S.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [8] Neurofilament light chain in the assessment of patients with multiple sclerosis
    Domingues, Renan Barros
    Peres Fernandes, Gustavo Bruniera
    Vilela de Moura Leite, Fernando Brunale
    Senne, Carlos
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2019, 77 (06) : 436 - 441
  • [9] NEUROFILAMENT LIGHT CHAIN AS A BIOMARKER FOR DIAGNOSIS OF MULTIPLE SCLEROSIS
    Kouchaki, Ebrahim
    Dashti, Fatemeh
    Mirazimi, Seyed Mohammad Ali
    Alirezaei, Zahra
    Jafari, Seyed Hamed
    Hamblin, Michael R.
    Mirzaei, Hamed
    EXCLI JOURNAL, 2021, 20 : 1308 - 1325
  • [10] Neurofilament Light Chain Correlates with Disease Activity while Both Neurofilament Light Chain and Glial Fibrillary Acidic Protein Associate with Disability in Pediatric Multiple Sclerosis
    Saucier, L.
    Healy, B. C.
    Saxena, S.
    Sanon, E. D.
    Saraceno, T. J.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 232 - 233
12345